Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 tria (Q82766552)
Jump to navigation
Jump to search
scientific article published on 29 November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 tria |
scientific article published on 29 November 2008 |
Statements
Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial (English)
Nicholas D James
Armelle Caty
Michael Borre
Bernard A Zonnenberg
Philippe Beuzeboc
Thomas Morris
De Phung
29 November 2008